Viewing Study NCT06348134


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-03-06 @ 2:04 PM
Study NCT ID: NCT06348134
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-03
First Post: 2024-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
Sponsor: University of Chicago
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2026-01-01
Start Date Type: ESTIMATED
Primary Completion Date: 2034-07-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2036-07-01
Completion Date Type: ESTIMATED
First Submit Date: 2024-03-29
First Submit QC Date: None
Study First Post Date: 2024-04-04
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-02
Last Update Post Date: 2025-07-03
Last Update Post Date Type: ACTUAL